Literature DB >> 1321807

Tyrosine phosphorylation of mitogen-activated protein kinase in cells with tyrosine kinase-negative epidermal growth factor receptors.

R Campos-González1, J R Glenney.   

Abstract

Epidermal growth factor (EGF) treatment of cells expressing the human EGF receptor (EGFr) results in rapid tyrosine phosphorylation of several cellular proteins including mitogen-activated protein (MAP) kinase. EGF treatment of cells expressing a tyrosine kinase-inactive EGFr failed to induce the tyrosine phosphorylation of endogenous substrates in response to EGF; however, the tyrosine phosphorylation and activation of MAP kinase did occur. This observation indicates that MAP kinase is activated in response to a signal other than the tyrosine kinase activity of the EGFr. Because EGF does not stimulate cells expressing the inactive EGFr to proliferate, phosphorylation of MAP kinase may not be sufficient for the EGF-dependent mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321807

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  p75(NGFR) and TrkA receptors collaborate to rapidly activate a p75(NGFR)-associated protein kinase.

Authors:  M Canossa; J L Twiss; A N Verity; E M Shooter
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

2.  Nucleotide-binding properties of kinase-deficient epidermal-growth-factor-receptor mutants.

Authors:  K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Authors:  M L Vignais; H B Sadowski; D Watling; N C Rogers; M Gilman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 4.  The autocrine loop of TGF-alpha/EGFR and brain tumors.

Authors:  P Tang; P A Steck; W K Yung
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

5.  A kinase-negative epidermal growth factor receptor that retains the capacity to stimulate DNA synthesis.

Authors:  K J Coker; J V Staros; C A Guyer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Activation of c-fos gene expression by a kinase-deficient epidermal growth factor receptor.

Authors:  E R Eldredge; G M Korf; T A Christensen; D C Connolly; M J Getz; N J Maihle
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

7.  Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun.

Authors:  E Cano; C A Hazzalin; L C Mahadevan
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity.

Authors:  D C Connolly; S L Toutenhoofd; N J Maihle
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  Transient activation of RAF-1, MEK, and ERK2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo.

Authors:  R A Hipskind; M Baccarini; A Nordheim
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  The secret life of kinases: functions beyond catalysis.

Authors:  Jens Rauch; Natalia Volinsky; David Romano; Walter Kolch
Journal:  Cell Commun Signal       Date:  2011-10-28       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.